Back

Dose antihypertensive medication improve accelerated age-dependent decline of GFR in hypertension?

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Challenges in hypertension treatment Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Hiroyuki Takase

Enshu Hospital, Hamamatsu (Japan)

9 More presentations in this session

Presentation thumbnail
Combined therapy of empagliflozin and linagliptin is superior to metformin and insulin glargine in improving blood pressure and vascular function in type 2 diabetes
Miss S. Jung (Erlangen, DE)
Abstract Slides Video
Presentation thumbnail
Effect of sodium glucose cotransporter 2 inhibitor on sympathetic nerve activity in type 2 diabetes mellitus patients
Doctor T. Hamaoka (Kanazawa, JP)
Abstract Slides Video
Presentation thumbnail
Adverse effects of spironolactone in long-term treatment of resistant arterial hypertension
Associate Professor J. Vaclavik (Ostrava, CZ)
Abstract Slides Video
Presentation thumbnail
The administration of an aldosterone antagonist as the second step of treatment improves efficacy and adherence at all hypertensive levels
Doctor V. Martire (La Plata, AR)
Presentation thumbnail
Peripheral edema and headache associated with amlodipine treatment: a meta-analysis of randomized, placebo-controlled trials
Doctor D. Vukadinovic (Homburg, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Challenges in hypertension treatment

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
The floor is yours: bring your questions about optimal blood pressure control for organ protection - expert panel
thumbnail
Congress Presentation
Hypertension, diabetes, and the kidney: a triple threat for adverse cardiovascular events?
thumbnail
Congress Presentation
Hypertension and glucose

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources